Differences between the oral changes presented by patients with solid and hematologic tumors during the chemotherapeutic treatment

Ribeiro, Isabella Lima Arrais; Silva, Sâmara Munique; Limeira, Rebecca Rhuanny Tolentino; Bonan, Paulo Rogério Ferreti; Valença, Ana Maria Gondim; Lima Neto, Eufrásio Andrade de; Castro, Ricardo Dias de.
J. appl. oral sci ; 28: e20190020, 2020. tab, graf
Artigo em Inglês | LILACS, BBO | ID: biblio-1056587

Similares

  1. Differences between the oral changes presented by patients with solid and hematologic tumors during the chemotherapeutic treatment.
  2. Oral microbial changes and oral disease management before and after the treatment of hematological malignancies: a narrative review.
  3. DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies.
  4. Subgroup analysis in haematologic malignancies phase III clinical trials: A systematic review.
  5. Developing a classification of hematologic neoplasms in the era of precision medicine.
  6. Telomerase inhibition in haematological neoplasms-are we ready for primetime?
  7. Antithrombotic secondary prophylaxis with low dose of apixaban or rivaroxaban in the onco-hematologic patients: comparison with non-neoplastic patients.
  8. The role of MOZ/KAT6A in hematological malignancies and advances in MOZ/KAT6A inhibitors.
  9. Diagnosis and classification of hematologic malignancies on the basis of genetics.
  10. [Immunogenic cell death in hematological malignancies].